• L&C Bio set the final issue price for its shareholder allocation capital raise at KRW 39,100 per share.
• Transaction covers 3,700,000 common shares with a par value of KRW 500 each.
• Final price reflects the lower of the first-stage price of KRW 39,100 or the second-stage price of KRW 42,400.
• Pricing was fixed on 2026-10-08.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. L&C Bio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261012900305), on October 12, 2026, and is solely responsible for the information contained therein.